“I think this really now suggests that Rezum is a financially viable procedure across these different treatment settings…the reimbursement now is really quite favorable,” says David M. Albala, MD.
In this video, David M. Albala, MD, discusses the recent change made by the Centers for Medicare & Medicaid Services regarding Rezum water vapor therapy. This new change allows for more financial coverage for patients with benign prostatic hyperplasia (BPH) who seek this treatment. Albala is a urologist at Associate Medical Professionals and chief of urology at Crouse Hospital in Syracuse, New York.
Can remote patient monitoring enhance your practice?
March 8th 2023“[The ability of] remote patient monitoring to provide targeted clinical information to physicians and elevate critical information for review and earlier intervention is enhancing patient communication and care delivery,” said Jim Brown, MD.
2 Clarke Drive
Cranbury, NJ 08512